MedTrace Logo

Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography in Patients With Multiple Sclerosis

NCT04702763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-01-27

No results posted yet for this study

Summary

This study aims to compare measurements obtained through the e-VOG application (mobile application, usable on mobile phones or tablets, to measure eye movements) with measurements from the standard video-oculography device (Eye-Tracker®T2), in patient with Multiple Sclerosis.

Conditions

Interventions

OTHER

Eye-Tracker®T2 + e-VOG

* 1st step: eyes movements assessed with standard video-oculography device * 2° step: eyes movements assessed with e-VOG digital application * Patient study duration is about 30 minutes, the day the patient performs their standard video-oculography examination in routine care

OTHER

e-VOG + Eye-Tracker®T2

* 1st step: eyes movements assessed with e-VOG digital application * 2° step: eyes movements assessed with standard video-oculography device * Patient study duration is about 30 minutes, the day the patient performs their standard video-oculography examination in routine care

Sponsors & Collaborators

  • Centre Hospitalier Princesse Grace

    collaborator OTHER

  • Centre Hospitalier Universitaire de Nice

    collaborator OTHER

  • Association de Recherche Bibliographique pour les Neurosciences

    lead OTHER

Principal Investigators

  • Mikael COHEN, MD · Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France

  • Christine LEBRUN-FRENAY, PUPH · Centre de Ressources et de Compétences SEP, UMRC Pasteur 2, Université Nice Côte d'Azur, Nice-France

  • Sandrine LOUCHART DE LA CHAPELLE, MD-PHD · Centre Mémoire, Centre de Gérontologie Clinique RAINIER III, Princess Grace Hospital, Monaco

  • Alain PESCE, PUPH · AREBISN (Association de Recherche Bibliographique pour les Neurosciences), Nice (France)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-08
Primary Completion
2021-10-30
Completion
2021-10-30

Countries

  • Monaco

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702763 on ClinicalTrials.gov